Topic
summit therapeutics
1 market across Kalshi and Polymarket, $28 traded today.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
 FDA decision: Ivonescimab by Summit Therapeutics (in 2026)EconomicsEnds Dec 31, 2026 | 85% | — |  88¢ | $28 |
Topic
1 market across Kalshi and Polymarket, $28 traded today.
| Market | Chance | 24h | Last 24h | Best price | Volume 24h |
|---|---|---|---|---|---|
| FDA decision: Ivonescimab by Summit Therapeutics (in 2026)EconomicsEnds Dec 31, 2026 | 85% | — | 88¢ | $28 |